Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Biochaperone® Combo

Subcutaneous injection of an individualized dose

DRUG

Humalog® Mix25

Subcutaneous injection of an individualized dose

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss